Home The Word Brain My Amedeo FAQ Privacy About   


Kitty Coach

For Chrome and Edge browsers



  Neoplasms of the CNS

  Free Subscription


03.02.2025

4 Br J Neurosurg
1 Childs Nerv Syst
2 Clin Cancer Res
2 Eur J Cancer
1 J Natl Cancer Inst
2 J Neurooncol
4 J Neurosurg
8 Neuro Oncol
2 Neurosurgery
5 PLoS One
2 Radiol Imaging Cancer


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Br J Neurosurg

  1. REVUELTA BARBERO JM, Soriano RM, Porto E, Bray DP, et al
    Purely nasal floor mucosa-free graft for reconstruction after endoscopic endonasal transellar approach: an anatomical and clinical analysis.
    Br J Neurosurg. 2025;39:78-83.
    PubMed         Abstract available

  2. GRAY WK, Navaratnam AV, Rennie C, Mendoza N, et al
    The volume-outcome relationship for endoscopic transsphenoidal pituitary surgery for benign neoplasm: analysis of an administrative dataset for England.
    Br J Neurosurg. 2025;39:44-51.
    PubMed         Abstract available

  3. DEY A, Bidkar PU, Swaminathan S, M MK, et al
    Comparison of two techniques of goal directed fluid therapy in elective neurosurgical patients - a randomized controlled study.
    Br J Neurosurg. 2023 Feb 3:1-9. doi: 10.1080/02688697.2023.2173722.
    PubMed         Abstract available

  4. ENDO M, Adachi JI, Murakami C, Inomoto C, et al
    A case of aggressive pituitary neuroendocrine tumour with extremely rapid progression: possible diagnostic value of TERT promoter methylation.
    Br J Neurosurg. 2025;39:93-99.
    PubMed         Abstract available


    Childs Nerv Syst

  5. ONG SH, Lim MJR, Tan CL, Kimpo MS, et al
    Rare regression of congenital brainstem high-grade glioma: case report and literature review.
    Childs Nerv Syst. 2025;41:94.
    PubMed         Abstract available


    Clin Cancer Res

  6. TILL JE, Seewald NJ, Yazdani Z, Wang Z, et al
    Corticosteroid-dependent association between prognostic peripheral blood cell-free DNA levels and neutrophil-mediated NETosis in patients with glioblastoma.
    Clin Cancer Res. 2025 Jan 31. doi: 10.1158/1078-0432.CCR-24-3169.
    PubMed         Abstract available

  7. STEFAN D, Lesueur P, Lequesne J, Feuvret L, et al
    Olaparib, temozolomide and concomitant radiotherapy for partially or biopsy-only glioblastoma first-line treatment: results from the OLA-TMZ-RTE-01 phase 1 study.
    Clin Cancer Res. 2025 Jan 30. doi: 10.1158/1078-0432.CCR-24-2974.
    PubMed         Abstract available


    Eur J Cancer

  8. PEDERSEN S, Johansen EL, Hojholt KL, Pedersen MW, et al
    Survival improvements in patients with melanoma brain metastases and leptomeningeal disease in the modern era: Insights from a nationwide study (2015-2022).
    Eur J Cancer. 2025;217:115253.
    PubMed         Abstract available

  9. PEARSON AD, Mueller S, Filbin MG, Grill J, et al
    Paediatric strategy forum for medicinal product development in diffuse midline gliomas in children and adolescents ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
    Eur J Cancer. 2025;217:115230.
    PubMed         Abstract available


    J Natl Cancer Inst

  10. PATEL B, Pugazenthi S, English CW, Nitturi V, et al
    NF2 loss-of-function and hypoxia drive radiation resistance in grade 2 meningiomas.
    J Natl Cancer Inst. 2025 Jan 30:djaf022. doi: 10.1093.
    PubMed         Abstract available


    J Neurooncol

  11. HUANG JY, Yeh TC, Liu HC, Hou JY, et al
    Computerized assessment of neuropsychological functioning in pediatric brain tumor patients.
    J Neurooncol. 2025 Jan 31. doi: 10.1007/s11060-025-04945.
    PubMed         Abstract available

  12. PETERSON RK, Choi JH, King TZ
    Demographic, medical, and neighborhood barriers to clinical neuropsychological services in pediatric medulloblastoma patients treated in the United States.
    J Neurooncol. 2025 Jan 28. doi: 10.1007/s11060-025-04940.
    PubMed         Abstract available


    J Neurosurg

  13. YOUNG JS, Semonche A, Morshed RA, Al-Adli NN, et al
    Focused ultrasound therapy as a strategy for improving glioma treatment.
    J Neurosurg. 2025 Jan 24:1-10. doi: 10.3171/2024.9.JNS24721.
    PubMed         Abstract available

  14. QIAO N, Li C, Zheng F, Zhang L, et al
    Development and validation of a radiomics-visual evoked potential nomogram for preoperative prediction of visual outcome after endoscopic craniopharyngioma resection.
    J Neurosurg. 2025 Jan 24:1-11. doi: 10.3171/2024.9.JNS241482.
    PubMed         Abstract available

  15. NGUYEN LV, Kam NM, Li SJ, Lee J, et al
    Noncontrast imaging for the surveillance of treated and untreated meningiomas.
    J Neurosurg. 2025 Jan 31:1-9. doi: 10.3171/2024.9.JNS241425.
    PubMed         Abstract available

  16. LI X, Shan B, Xu J
    Letter to the Editor. Feasibility of causal relationship between obesity and meningioma.
    J Neurosurg. 2025 Jan 31:1-2. doi: 10.3171/2024.10.JNS242582.
    PubMed        


    Neuro Oncol

  17. CHEN YM, Chambon J, Moquin A, Hashimoto M, et al
    Nanoparticle encapsulation enables systemic IGF-Trap delivery to inhibit intra-cerebral glioma growth.
    Neuro Oncol. 2025 Jan 29:noaf011. doi: 10.1093.
    PubMed         Abstract available


  18. Erratum to: Maternal obesogenic diet operates at the tumor cell of origin to increase incidence and decrease latency of neurofibromatosis type 1 optic pathway glioma.
    Neuro Oncol. 2025 Jan 29:noaf010. doi: 10.1093.
    PubMed        

  19. ZHANG X, Jiang M, Niu W, Xu B, et al
    CircPRKD3-loaded exosomes concomitantly elicit tumor growth inhibition and glioblastoma microenvironment remodeling via inhibiting STAT3 signaling.
    Neuro Oncol. 2025 Jan 27:noaf019. doi: 10.1093.
    PubMed         Abstract available

  20. CHATTERJEE J, Qi X, Mu R, Li X, et al
    Intestinal Bacteroides drives glioma progression by regulating CD8+ T cell tumor infiltration.
    Neuro Oncol. 2025 Jan 27:noaf024. doi: 10.1093.
    PubMed         Abstract available

  21. LANDRY AP, Wang JZ, Yefet LS, Liu J, et al
    Metabolic profiling of meningioma reveals novel subgroup-specific biologic insights and outcome dependencies.
    Neuro Oncol. 2025 Jan 24:noae281. doi: 10.1093.
    PubMed         Abstract available

  22. TAMBORINI M, Ribecco V, Stanzani E, Sironi A, et al
    Extracellular Vesicles Released by Glioblastoma Cancer Cells Drive Tumor Invasiveness via Connexin-43 Gap Junctions.
    Neuro Oncol. 2025 Jan 30:noaf013. doi: 10.1093.
    PubMed         Abstract available

  23. GREENBERG I, Khair F, Merenbakh-Lamin K, Sokol E, et al
    IRS2 as a driver of brain metastasis in colorectal cancer: a potential target for novel therapeutic strategies.
    Neuro Oncol. 2025 Jan 31:noaf028. doi: 10.1093.
    PubMed         Abstract available

  24. DE LA FUENTE MI, Lassman AB
    Pre-Radiation Targeted Therapy for Highly Selected Patients with Newly Diagnosed Glioblastoma: New Tricks for an Old Dog?
    Neuro Oncol. 2025 Jan 24:noaf014. doi: 10.1093.
    PubMed        


    Neurosurgery

  25. DEMASI M, Elia A, Simboli GA, Moiraghi A, et al
    Feasibility, Safety, and Impact of Awake Resection for Recurrent Insular Diffuse Gliomas in Adults.
    Neurosurgery. 2025 Jan 29. doi: 10.1227/neu.0000000000003366.
    PubMed         Abstract available

  26. BONO BC, Grimi A, Di Toro AE, Ninatti G, et al
    Preoperative Diffusion Tensor Imaging and Neurite Dispersion and Density Imaging in Isocitrate Dehydrogenase-Mutant Grade 2 and 3 Gliomas: Definition of Tumor-Related Epilepsy and Predictive Factors of Seizure Outcomes Based on a Single-Center Retrosp
    Neurosurgery. 2025 Jan 29. doi: 10.1227/neu.0000000000003365.
    PubMed         Abstract available


    PLoS One

  27. GRIFFITHS-KING DJ, Delivett C, Peet A, Waite J, et al
    Limited research investigating the value of MRI in predicting future cognitive morbidity in survivors of paediatric brain tumours: A systematic-review and call to action for clinical neuroimaging researchers.
    PLoS One. 2025;20:e0314721.
    PubMed         Abstract available

  28. PANDEY R, Natarajan P, Reddy UK, Du W, et al
    Deciphering the dose-dependent effects of thymoquinone on cellular proliferation and transcriptomic changes in A172 glioblastoma cells.
    PLoS One. 2025;20:e0318185.
    PubMed         Abstract available

  29. LEE KS, Borbas B, Chaudhry D, Kuri A, et al
    Surgical Site Infection after Craniotomy in Neuro-Oncology (SINO): A protocol for an international prospective multicentre service evaluation across the United Kingdom and Ireland.
    PLoS One. 2025;20:e0316237.
    PubMed         Abstract available

  30. DARWISH H, Diab T, Kawtharani S, Barake M, et al
    Impact of re-operation on progression-free survival in patients with recurrent GBM: Experience in a tertiary referral center.
    PLoS One. 2025;20:e0317937.
    PubMed         Abstract available

  31. HE XY, Yang YS, Zheng YX, Xia QJ, et al
    Scutellarin combined with lidocaine exerts antineoplastic effect in human glioma associated with repression of epidermal growth factor receptor signaling.
    PLoS One. 2025;20:e0318031.
    PubMed         Abstract available


    Radiol Imaging Cancer

  32. WEGSCHEID M
    Reevaluating Pediatric Brain Tumor Perfusion Imaging.
    Radiol Imaging Cancer. 2025;7:e259003.
    PubMed        

  33. HARLIANTO NI
    Measurable Disease in Glioblastoma using PET-based Response Assessment in Neuro-Oncology (PET RANO 1.0).
    Radiol Imaging Cancer. 2025;7:e259001.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.